Amblee Ambika, Uy Juanito, Senseng Carmencita, Hart Peter
Division of Endocrinology , John Stroger Hospital of Cook County , Chicago, IL 60612 , USA ; Rush University Medical Center , Chicago, IL 60612 , USA.
Elkhart Clinic , Elkhart, IN 46514 , USA.
Clin Kidney J. 2014 Apr;7(2):186-9. doi: 10.1093/ckj/sfu004. Epub 2014 Feb 25.
A 38-year-old man presenting with long bone/rib fractures was diagnosed with tumor-induced osteomalacia (TIO) caused by a giant cell tumor in the right foot with normal systemic fibroblast growth factor-23 (FGF23) levels. Multiple imaging modalities done initially and one year later were unable to localize the tumor. New-onset foot pain discovered a right foot mass with resolution of metabolic abnormalities post-surgery. Sampling from both femoral veins showed an elevated FGF23 value on the right side. This case is unique in that the patient had a normal systemic FGF23 level even with severe clinical manifestations of TIO.
一名38岁男性因长骨/肋骨骨折就诊,被诊断为肿瘤性骨软化症(TIO),由右脚巨细胞瘤引起,全身成纤维细胞生长因子-23(FGF23)水平正常。最初及一年后进行的多种影像学检查均未能定位肿瘤。新发的足部疼痛发现右脚有肿物,手术后代谢异常得以缓解。双侧股静脉采样显示右侧FGF23值升高。该病例的独特之处在于,即使患者有TIO的严重临床表现,其全身FGF23水平仍正常。